Health
UK Launches 3rd Booster Dose Trial of 7 COVID-19 Vaccines Including Oxford-AstraZeneca, Pfizer-BioNTech And – LatestLY
In a first, the UK has launched a new clinical trial that will assess the efficacy of a third ‘booster’ dose of seven different COVID-19 vaccines on patients’ immune…
London, May 21: In a first, the UK has launched a new clinical trial that will assess the efficacy of a third ‘booster’ dose of seven different COVID-19 vaccines on patients’ immune responses, the media reported.
The trial will assess COVID-19 vaccines of Oxford-AstraZeneca, Pfizer-BioNTech, Moderna, Novavax, Valneva, Janssen and Curevac. COVID-19 Cases Will Rise Despite Vaccination: UK Scientists
The trial, named Cov-Boost, aims to begin in June and recruit 3,000 people of all ages who had their…
-
Noosa News18 hours agoYoung voices shape Sunshine Coast’s future
-
Business18 hours ago2 Low Cost Active ASX ETFs to consider
-
Noosa News16 hours agoAnother All-Star Cast, Another Tale of Family Chaos: The Trailer for Wes Anderson’s ‘The Phoenician Scheme’ Is Here
-
Business14 hours agoshould I buy hedged or unhedged ASX US-focused ETFs?